Fubotv earnings beat by $0.10, revenue topped estimates
Investing.com - Truist Securities has reiterated its Buy rating on National Health Investors (NYSE:NHI) with a price target of $77.00. The healthcare REIT, currently trading at $74.01 with a market capitalization of $3.48 billion, maintains a "GREAT" financial health score according to InvestingPro analysis.
The firm cited National Health Investors’ second-quarter normalized FFO results, which exceeded both Truist’s estimate and the consensus forecast. Management also raised its full-year guidance by more than the amount of the quarterly beat.
National Health Investors increased its quarterly dividend for the first time in five years, which Truist Securities interpreted as reflecting strength and confidence in the company’s current condition and forward outlook.
The research note highlighted that occupancy and rent coverage remain high for the healthcare real estate investment trust. National Health Investors’ senior housing operating portfolio (SHOP) is growing through strong organic growth, operator transitions, and new investments.
Truist Securities analyst Michael Lewis (JO:LEWJ) suggested the earnings release may have a slightly positive impact on the stock price.
In other recent news, National Health Investors has seen notable developments. KeyBanc has upgraded the company’s stock rating from Sector Weight to Overweight, setting a price target of $80.00, citing potential value-creation opportunities such as unscheduled deferral repayments and strong investment execution. Similarly, Truist Securities has upgraded National Health Investors from Hold to Buy, maintaining a price target of $77.00, and highlighting its low leverage and high forecasted earnings growth rates.
Additionally, the company announced the preliminary results of its 2025 Annual Meeting of Stockholders, where all four director nominees were elected. The elected directors are Robert G. Adams, Robert W. Chapin, Jr., James R. Jobe, and Candice W. Todd. National Health Investors has expressed appreciation for shareholder engagement and emphasized its commitment to improving corporate governance.
In another development, Glass Lewis, a proxy advisory firm, has recommended shareholders vote for two independent nominees proposed by Land & Buildings Investment Management for the company’s board. Glass Lewis has raised concerns about the objectivity of some current director candidates due to their long-standing ties with National Healthcare Corp.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.